24/04/2026
Invitation to Scientific Meeting: Prostate Brachytherapy - Optimizing Outcomes in Prostate Cancer
Bayer, in proud collaboration with the Iraqi Society of Clinical Oncology (ISCO), cordially invites you to an upcoming scientific webinar dedicated to advancements in prostate cancer treatment.
Session Overview
Topic: Optimizing Outcomes — Brachytherapy for Prostate Cancer
Date: Saturday, April 25, 2026
Time: 09:00 PM – 10:00 PM (Baghdad Time)
Distinguished Speaker
Dr. Hathal Haddad
An esteemed authority in the field, Dr. Haddad brings a wealth of clinical and academic expertise to this session. His distinguished profile includes:
Head of Interventional Radiotherapy Unit
Editorial Board Member, Brachytherapy Journal
UroGec Ambassador
Expert in AI Integration within Radiation Oncology
Advocate for Empathy Medicine, balancing technical precision with patient-centered care.
Objective
This meeting aims to explore the latest clinical protocols and technological integrations in brachytherapy. Attendees will gain insights into maximizing therapeutic efficacy and improving long-term patient outcomes through precision interventional radiotherapy.
We look forward to your presence at this high-level academic exchange.Bayer Cordially invites you to attend the scientific meeting.
Topic: Optimizing Outcomes - Brachytherapy for Prostate Cancer.
Educator: Dr. Hathal Haddad.
Head of Interventional Radiotherapy Unit | Editorial Board Brachytherapy Journal | UroGec Ambassador |Medical Speaker, Researcher & Writer | AI in Radiation Oncology | Empathy Medicine.
Time: 25-04-2026, 09:00 - 10:00 PM Baghdad Time.
Zoom link: https://bayer.zoom.us/j/91040891115
